NCT06944925View on ClinicalTrials.gov

A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE1RecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

May 8, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

March 31, 2027

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

BBT002

BBT002 will be administered.

DRUG

Placebo

Placebo will be administered.

Trial Locations (1)

6009

RECRUITING

Linear Clinical Research, Perth

Sponsors
All Listed Sponsors
lead

Bambusa Therapeutics

INDUSTRY